Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2026-09
Primary completion Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06645249
2026-09
Study completion Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06750341
2026-09-30
Study completion Nebivolol ANOCA Treatment Randomized Trial Registry record
Expected 2026-09-30; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06755801
2026-09
Primary completion A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07021976
2026-09
Primary completion A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07100418
2026-09
Primary completion Pivotal Study of the Velocity™ pAVF System Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07153939
2026-09
2026-09
Study completion Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital Monitoring Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07260721
2026-09-30
Primary completion Post-stroke Nurse-led Rehabilitation to Improve Functional Activity and Community Participation in Bangladesh Registry record
Expected 2026-09-30; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07384650
2026-09
Study start Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07405671
2026-09
Study start triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07440381
2026-09-30
Study start Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) Registry record
Expected 2026-09-30; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07468448
2026-09
2026-09
Study start GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07617155
2026-09
Study start BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07628985
2026-09-30
Primary completion Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial Registry record
Expected 2026-09-30; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07648693
2026-09
Study start An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes. Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07661381
2026-09-30
Study start Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial Registry record
Expected 2026-09-30; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07746271
2026-09
Study start Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07781462
2026-09
Study start Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07801599
2026-09
Study start KV-PREDICT Diagnostic Device in Patients With Heart Failure Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07805213
2026-09
Study start Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07811934
2026-09-30
Study start A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy Registry record
Expected 2026-09-30; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07816198
2026-09
Study start A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07833098
2026-09
Study start Post-Marketing Clinical Study of High-Pressure Cutting Balloon Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07835178
2026-09
Study start OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) Registry record
Expected 2026-09; that period ended on 2026-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07855614
2026-10-01
Primary completion Vasoactive Drugs in Intensive Care Unit Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02118467
2026-10-01
Study completion Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05930145
2026-10-01
Study completion Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06029166
2026-10-01
Primary completion Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06029166
2026-10-01
Study completion REBOA in Nontraumatic OHCA Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06031623
2026-10-01
Primary completion A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06200207
2026-10-01
Primary completion Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06701825
2026-10-01
2026-10-01
2026-10-01
Study completion Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06989892
2026-10-01
Primary completion Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07200180
2026-10-01
Primary completion Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07397351
2026-10-01
Study completion Engaging Home-monitored Assessment to Navigate Clinical Decision-making Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07399912
2026-10-01
Primary completion Engaging Home-monitored Assessment to Navigate Clinical Decision-making Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07399912
2026-10-01
Primary completion VASC-AF Study: Vascular Closure vs Manual Compression Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07414121
2026-10-01
Primary completion Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07508254
2026-10-01
Primary completion AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07512206
2026-10-01
Study start AI-Assisted Workflow for Occult Atrial Fibrillation Detection After Ischemic Stroke: A Prospective Randomized Trial Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07540065
2026-10-01
Study start Remote Monitoring and Optimization of Heart Failure Therapy Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07622472
2026-10-01
Study start LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07645300
2026-10-01
Study start A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07645586
2026-10-01
2026-10-01
2026-10-01
2026-10-01
Study start PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07739537
2026-10-01
Study start Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07743697
2026-10-01
Study start APEX-STROKE CALM-ICH Domain Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07752719
2026-10-01
Study start Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07760922
2026-10-01
Study start Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT) Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07771491
2026-10-01
Study start Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07824492
2026-10-01
Study start EECP for Erectile Dysfunction in Elderly Hypertensive Patients Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07831551
2026-10-01
Study start Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07841080
2026-10-01
2026-10-01
Study start Vortosiran in Atrial Fibrillation Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07870889
2026-10-01
Study start Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07877116
2026-10-01
Study start CATCH AF - Atrial Fibrillation Detection in Cryptogenic Stroke Registry record
Expected 2026-10-01; that period ended on 2026-10-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07899788
2026-10-05
Study completion REmote COnditioning in Out-of-Hospital Cardiac Arrest Registry record
Expected 2026-10-05; that period ended on 2026-10-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06306625
2026-10-06
2026-10-07
Study completion RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Registry record
Expected 2026-10-07; that period ended on 2026-10-07.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07203521
2026-10-08
2026-10-10
Primary completion Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus Registry record
Expected 2026-10-10; that period ended on 2026-10-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07193459
2026-10-12
Study completion DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Registry record
Expected 2026-10-12; that period ended on 2026-10-12.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05764057
2026-10-12
Primary completion DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Registry record
Expected 2026-10-12; that period ended on 2026-10-12.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05764057
2026-10-14
Primary completion Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock Registry record
Expected 2026-10-14; that period ended on 2026-10-14.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04184635
2026-10-14
Study completion Phimume® Percutaneous Left Ventricular Assist System Study Registry record
Expected 2026-10-14; that period ended on 2026-10-14.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06639321
2026-10-15
Study completion A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE Registry record
Expected 2026-10-15; that period ended on 2026-10-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05702034
2026-10-15
Primary completion A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE Registry record
Expected 2026-10-15; that period ended on 2026-10-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05702034
2026-10-15
2026-10-15
Study start A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension Registry record
Expected 2026-10-15; that period ended on 2026-10-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07647003
2026-10-15
Study start Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Registry record
Expected 2026-10-15; that period ended on 2026-10-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07730840
2026-10-16
Study completion Heart Failure Precision Medicine Study Registry record
Expected 2026-10-16; that period ended on 2026-10-16.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04196842
2026-10-16
Primary completion Heart Failure Precision Medicine Study Registry record
Expected 2026-10-16; that period ended on 2026-10-16.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04196842
2026-10-16
Study completion Diabetes Clinical Decision Support Registry record
Expected 2026-10-16; that period ended on 2026-10-16.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05447806
2026-10-18
Primary completion Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers Registry record
Expected 2026-10-18; that period ended on 2026-10-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07033585
2026-10-18
Study completion Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Registry record
Expected 2026-10-18; that period ended on 2026-10-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07279493
2026-10-18
Primary completion Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Registry record
Expected 2026-10-18; that period ended on 2026-10-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07279493
2026-10-19
Study start TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention Registry record
Expected 2026-10-19; that period ended on 2026-10-19.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07899021
2026-10-19
Study start Evaluating a Digital Aid to Improve ICD Decisions Registry record
Expected 2026-10-19; that period ended on 2026-10-19.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07913204
2026-10-20
Study start Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia Registry record
Expected 2026-10-20; that period ended on 2026-10-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07827521
2026-10-22
Primary completion Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment Registry record
Expected 2026-10-22; that period ended on 2026-10-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07403669
2026-10-23
Study start Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record
Expected 2026-10-23; that period ended on 2026-10-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07632898
2026-10-25
Study start PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk Registry record
Expected 2026-10-25; that period ended on 2026-10-25.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07741253
2026-10-25
Study start Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients Registry record
Expected 2026-10-25; that period ended on 2026-10-25.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07877103
2026-10-26
2026-10-26
Study start Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke Registry record
Expected 2026-10-26; that period ended on 2026-10-26.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07609654
2026-10-26
Study start Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli Registry record
Expected 2026-10-26; that period ended on 2026-10-26.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07794306
2026-10-27
Study completion Atrasentan in Patients With Proteinuric Glomerular Diseases Registry record
Expected 2026-10-27; that period ended on 2026-10-27.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04573920
2026-10-27
2026-10-28
Study start Dynamic Stabilometry Combined With Transcranial Direct Current Stimulation for Balance and Motor Recovery After Ischemic Stroke Registry record
Expected 2026-10-28; that period ended on 2026-10-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07912151
2026-10-30
Study completion Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05469659
2026-10-30
2026-10-30
Study completion Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06144125
2026-10-30
Study completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06189950
2026-10-30
Primary completion Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke Registry record
Expected 2026-10-30; that period ended on 2026-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06645522